Dongyang
Tang
a,
Xin
Zhao
b,
Tie
Yang
c and
Cheng
Wang
*d
aDepartment of Experimental Center, Henan Institute of Science and Technology, Xinxiang, Henan 453003, P. R. China
bDepartment of Pharmacy, Xinxiang Central Hospital, Xinxiang, Henan 453000, P. R. China
cNanjing Research Center, Jiangsu Chiatai Tianqing Pharmaceutical Co. Ltd, Nanjing, Jiangsu 210042, P. R. China
dCollege of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang 310058, P. R. China. E-mail: 11519016@zju.edu.cn
First published on 2nd April 2020
Correction for ‘Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy’ by Dongyang Tang et al., RSC Adv., 2018, 8, 380–389.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2020 |